Press releases

(French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

Press release | 16 Oct 2012 - 11h08 | By INSERM PRESS OFFICE
Cancer

TO CITE THIS POST :
Press release – Inserm press room (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses Link : https://presse.inserm.fr/en/french-un-test-automatis-pour-valuer-la-migration-cellulaire-et-l-efficacit-de-nouvelles-mol-cules-anticanc-reuses/4636/

Other contents In the same category :

Cancer Voir tout

communi

Inserm Research Director Jérôme Galon Wins European Inventor Award 2019

Inserm researcher Jérôme Galon has been honored by the European Patent Office (EPO) for his Immunoscore®, a test that predicts relapse risk in patients with certain forms of cancer. An achievement that encapsulates the missions and results of Inserm, a research institute ...
communi

A Vaccine to Overcome Immunotherapy Resistance

Researchers have shown that a commercially-available vaccine can overcome resistance to immunotherapy. Their study, published in Science Translational Medicine, shows that not only can gastroenteritis vaccines induce the immunogenic death of cancer cells in vitro, but also that combining them with immunotherapy ...
fermer
fermer
RSS Youtube